Predictors of clinically inactive disease at one year in 60 patients with polyarticular juvenile idiopathic arthritis receiving very early disease-modifying or biologic drug therapy. ACUTE-JIA study

被引：0
|
作者：
Tynjala, Pirjo
Vahasalo, Paula
Tarkiainen, Maarit
Aalto, Kristiina
Kroger, Liisa
Malin, Merja
Putto-Laurila, Anne
Honkanen, Visa
Landenne, Pekka
机构：
[1] Univ Helsinki, Cent Hosp, Childrens Hosp, FIN-00014 Helsinki, Finland
[2] Oulu Univ Hosp, Oulu, Finland
[3] Kuopio Univ Hosp, Kuopio, Finland
[4] Tampere Univ Hosp, Tampere, Finland
[5] Turku Univ Hosp, Turku, Finland
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2011年 / 29卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：420 / 420
页数：1
相关论文
共 20 条
  • [1] ATTAINMENT OF INACTIVE DISEASE WITH BIOLOGIC THERAPY IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS (JIA)
    Meiorin, S.
    Ahumada, F.
    Espada, G.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S120 - S120
  • [2] Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial
    Tynjala, Pirjo
    Vahasalo, Paula
    Tarkiainen, Maarit
    Kroger, Liisa
    Aalto, Kristiina
    Malin, Merja
    Putto-Laurila, Anne
    Honkanen, Visa
    Lahdenne, Pekka
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (09) : 1605 - 1612
  • [3] Predictors and Sustainability Of Clinical Inactive Disease In Polyarticular Juvenile Idiopathic Arthritis Given Aggressive Therapy Very Early In The Disease Course.
    Wallace, Carol A.
    Giannini, Edward H.
    Spalding, Steven J.
    Hashkes, Philip J.
    O'Neil, Kathleen M.
    Zeft, Andrew S.
    Szer, Ilona S.
    Ringold, Sarah
    Brunner, Hermine I.
    Schanberg, Laura E.
    Sundel, Robert P.
    Milojevic, Diana
    Punaro, Marilynn G.
    Chira, Peter
    Gottlieb, Beth S.
    Higgins, Gloria C.
    Ilowite, Norman T.
    Kimura, Yukiko
    Johnson, Anne
    Huang, Bin
    Lovell, Daniel J.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S334 - S335
  • [4] SUBCUTANEOUS ABATACEPT IN PATIENTS WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS AND INADEQUATE RESPONSE TO BIOLOGIC OR NON-BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS: PHARMACOKINETICS, EFFICACY AND SAFETY
    Ruperto, N.
    Lovell, D. J.
    Tzaribachev, N.
    Vega-Cornejo, G.
    Louw, I.
    Berman, A.
    Calvo, I.
    Cuttica, R.
    Horneff, G.
    Avila-Zapata, F.
    Anton, J.
    Viola, D.
    Foeldvari, I.
    Keltsev, V.
    Kingsbury, D.
    Li, X.
    Nys, M.
    Wong, R.
    Banerjee, S.
    Martini, A.
    Brunner, H. I.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 138 - 138
  • [5] Clinically Inactive Disease in a Cohort of Children with New-onset Polyarticular Juvenile Idiopathic Arthritis Treated with Early Aggressive Therapy: Time to Achievement, Total Duration, and Predictors
    Wallace, Carol A.
    Giannini, Edward H.
    Spalding, Steven J.
    Hashkes, Philip J.
    O'Neil, Kathleen M.
    Zeft, Andrew S.
    Szer, Ilona S.
    Ringold, Sarah
    Brunner, Hermine I.
    Schanberg, Laura E.
    Sundel, Robert P.
    Milojevic, Diana S.
    Punaro, Marilynn G.
    Chira, Peter
    Gottlieb, Beth S.
    Higgins, Gloria C.
    Ilowite, Norman T.
    Kimura, Yukiko
    Johnson, Anne
    Huang, Bin
    Lovell, Daniel J.
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (06) : 1163 - 1170
  • [6] Predictors at diagnosis for start of biologic disease-modifying antirheumatic drugs in patients with early rheumatoid arthritis: a cohort study
    Hameed, Mohaned
    Exarchou, Sofia
    Eberhard, Anna
    Sharma, Ankita
    Bergstrom, Ulf
    Cagnotto, Giovanni
    Einarsson, Jon Thorkell
    Turesson, Carl
    BMJ OPEN, 2024, 14 (02):
  • [7] Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease
    Lovell, Daniel J.
    Johnson, Anne L.
    Huang, Bin
    Gottlieb, Beth S.
    Morris, Paula W.
    Kimura, Yukiko
    Onel, Karen
    Li, Suzanne C.
    Grom, Alexei A.
    Taylor, Janalee
    Brunner, Hermine I.
    Huggins, Jennifer L.
    Nocton, James J.
    Haines, Kathleen A.
    Edelheit, Barbara S.
    Shishov, Michael
    Jung, Lawrence K.
    Williams, Calvin B.
    Tesher, Melissa S.
    Costanzo, Denise M.
    Zemel, Lawrence S.
    Dare, Jason A.
    Passo, Murray H.
    Ede, Kaleo C.
    Olson, Judyann C.
    Cassidy, Elaine A.
    Griffin, Thomas A.
    Wagner-Weiner, Linda
    Weiss, Jennifer E.
    Vogler, Larry B.
    Rouster-Stevens, Kelly A.
    Beukelman, Timothy
    Cron, Randy Q.
    Kietz, Daniel
    Schikler, Kenneth
    Schmidt, Kara M.
    Mehta, Jay
    Wahezi, Dawn M.
    Ting, Tracy V.
    Verbsky, James W.
    Eberhard, B. Anne
    Spalding, Steven
    Chen, Chen
    Giannini, Edward H.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70 (09) : 1508 - 1518
  • [8] Subcutaneous Abatacept in Patients with Polyarticular-Course Juvenile Idiopathic Arthritis and Inadequate Response to Biologic or Non-Biologic Disease-Modifying Antirheumatic Drugs: Pharmacokinetics, Efficacy and Safety
    Lovell, D. J.
    Ruperto, N.
    Tzaribachev, N.
    Vega-Cornejo, G.
    Louw, I.
    Berman, A.
    Calvo, I.
    Cuttica, R.
    Horneff, G.
    Avila-Zapata, F.
    Anton, J.
    Cimaz, R.
    Solau-Gervais, E.
    Joos, R.
    Espada, G.
    Li, X.
    Nys, M.
    Wong, R.
    Banerjee, S.
    Brunner, Hermine I.
    Martini, A.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [9] SUBCUTANEOUS ABATACEPT IN PATIENTS WITH POLYARTICULAR-COURSE JUVENILE IDIOPATHIC ARTHRITIS AND INADEQUATE RESPONSE TO BIOLOGIC OR NON-BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS: PHARMACOKINETICS, EFFICACY AND SAFETY
    Ruperto, Nicolino
    Lovell, Daniel J.
    Tzaribachev, Nikolay
    Vega-Cornejo, Gabriel
    Louw, Ingrid
    Berman, Alberto
    Calvo, Inmaculada
    Cuttica, Ruben
    Horneff, Gerd
    Avila-Zapata, Francisco
    Anton, Jordi
    Cimaz, Rolando
    Solau-Gervais, Elisabeth
    Joos, Rik
    Espada, Graciela
    Li, Xiaohui
    Nys, Marleen
    Wong, Robert
    Banerjee, Subhashis
    Brunner, Hermine I.
    Martini, Alberto
    RHEUMATOLOGY, 2017, 56 : 40 - 41
  • [10] Timing matters: real-world effectiveness of early combination of biologic and conventional synthetic disease-modifying antirheumatic drugs for treating newly diagnosed polyarticular course juvenile idiopathic arthritis
    Huang, Bin
    Qiu, Tingting
    Chen, Chen
    Zhang, Yin
    Seid, Michael
    Lovell, Dan
    Brunner, Hermine I.
    Morgan, Esi M.
    RMD OPEN, 2020, 6 (01):
12